CBI’s pharmaceutical tax conference addresses timely and relevant corporate tax matters impacting life science companies. Through a series of presentations, closed-door forums and industry-only dialogue, pharmaceutical and biotechnology corporate tax and transfer pricing professionals gain a comprehensive update on legislative developments, IRS rulings and tax planning opportunities.

Topics covered include:

  • Federal Legislation
  • Territorial Income
  • Industry Fees
  • Transfer Pricing
  • Supply Chain Tax Planning
  • Implications of UTP Disclosure
  • Codification of “Economic Substance”
  • R&D Credits
  • IRS Transfer Pricing Audits

John T. Hildy

For more information on this event and to register please, click here.